---
title: "RAVIV ADI — Ownership Dossier"
canonical: https://whiteintel.dev/entity/9c613ca7-e7ac-52f6-99d4-eda3ae185e49
json: https://whiteintel.dev/api/public/dossier/9c613ca7-e7ac-52f6-99d4-eda3ae185e49
identifier: sec:0001098565
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# RAVIV ADI

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001098565`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/9c613ca7-e7ac-52f6-99d4-eda3ae185e49  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/9c613ca7-e7ac-52f6-99d4-eda3ae185e49  

## Ownership & control

### Holdings / subsidiaries

- **BIONDVAX PHARMACEUTICALS LTD.** (director) — https://whiteintel.dev/entity/1215b2d5-78a0-5b8e-ba67-3e618c7a43b2

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **RAVIV ADI**. Human view: https://whiteintel.dev/entity/9c613ca7-e7ac-52f6-99d4-eda3ae185e49 · Structured JSON: https://whiteintel.dev/api/public/dossier/9c613ca7-e7ac-52f6-99d4-eda3ae185e49._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._